Cell Medica Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cell Medica Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0480
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cell Medica Ltd (Cell Medica), formerly Immunocode Ltd manufactures and commercializes cellular products. The company uses various technology platforms such as chimeric antigen receptor (CAR), Dominant T cell receptor (TCR), PENTRA Antibody technology and NKT cell platform for manufacturing gene-modified immune cell products. Its pipeline products include CAR-NKT Cells, Dominant TCR and EBV- Targeted T Cells. Cell Medica collaborates with academic institutions to harness human immune system for the treatment of cancer. The company operates in Switzerland, the UK and the US. Cell Medica is headquartered in London, the UK.

Cell Medica Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cell Medica Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cell Medica Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Cell Medica Raises USD73.2 Million in Series C Financing 11
Cell Medica Raises USD78.3 Million in Series B Venture Financing 12
Delenex Therapeutics Raises US$8 Million In Series A3 Financing 13
Cell Medica Raises US$11 Million In Venture Financing 14
Partnerships 15
Cell Medica Enters into Partnership with University College London 15
Licensing Agreements 16
Cell Medica Extends Licensing Agreement with Baylor College of Medicine 16
Acquisition 18
Cell Medica Acquires Catapult Therapy TCR from Cell Therapy Catapult 18
Cell Medica Acquires Remaining 73% Stake in Delenex Therapeutics 19
Cell Medica Ltd – Key Competitors 20
Cell Medica Ltd – Key Employees 21
Cell Medica Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Corporate Communications 23
Jun 13, 2018: Cell Medica Names Julia P. Gregory As Non-Executive Director And Audit Chair 23
Feb 16, 2018: Cell Medica Appoints Kevin S. Boyle As CFO 24
Dec 07, 2017: Cell Medica Announces Appointment of Industry Leader Dr Annalisa Jenkins as Chair 25
Sep 18, 2017: Cell Medica Appoints CSO to Accelerate R&D for CAR and TCR Programmes 26
Product Approvals 27
Feb 21, 2017: Lead cancer immunotherapy candidate receives FDA fast track designation 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Cell Medica Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cell Medica Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cell Medica Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Cell Medica Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cell Medica Raises USD73.2 Million in Series C Financing 11
Cell Medica Raises USD78.3 Million in Series B Venture Financing 12
Delenex Therapeutics Raises US$8 Million In Series A3 Financing 13
Cell Medica Raises US$11 Million In Venture Financing 14
Cell Medica Enters into Partnership with University College London 15
Cell Medica Extends Licensing Agreement with Baylor College of Medicine 16
Cell Medica Acquires Catapult Therapy TCR from Cell Therapy Catapult 18
Cell Medica Acquires Remaining 73% Stake in Delenex Therapeutics 19
Cell Medica Ltd, Key Competitors 20
Cell Medica Ltd, Key Employees 21
Cell Medica Ltd, Other Locations 22
Cell Medica Ltd, Subsidiaries 22

List of Figures
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cell Medica Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Cell Medica Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sinclair Oil Corp:企業の戦略的SWOT分析
    Sinclair Oil Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Belize Electricity Ltd:企業の戦略的SWOT分析
    Belize Electricity Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Huatai Securities Co., Ltd. (601688):企業の財務・戦略的SWOT分析
    Huatai Securities Co., Ltd. (601688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Boart Longyear Ltd:企業の戦略・SWOT・財務情報
    Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report Summary Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Altadis USA Inc:企業の戦略・SWOT・財務情報
    Altadis USA Inc - Strategy, SWOT and Corporate Finance Report Summary Altadis USA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sparton Resources Inc (SRI):企業の財務・戦略的SWOT分析
    Summary Sparton Resources Inc (Sparton Resources) is a diversified company that acquires and develops oil and gas properties in North America and China. The company’s products include vanadium, natural gas, crude oil, gold, and vanadium flow batteries, among others. Its energy projects comprise Sier …
  • Confused.com Limited:企業の戦略・SWOT・財務情報
    Confused.com Limited - Strategy, SWOT and Corporate Finance Report Summary Confused.com Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sonoco Products Company:企業の戦略・SWOT・財務情報
    Sonoco Products Company - Strategy, SWOT and Corporate Finance Report Summary Sonoco Products Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • BioTime Inc (BTX):企業の財務・戦略的SWOT分析
    BioTime Inc (BTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Immunomedics Inc (IMMU)-医療機器分野:企業M&A・提携分析
    Summary Immunomedics Inc (Immunomedics) is a clinical-stage bio-pharmaceutical company that researches, develops, manufactures and commercializes monoclonal antibody-based drugs for the treatment of cancer and automimmune disorders. The company’s portfolio of antibody-drug conjugates are aimed to sp …
  • CorMedix Inc (CRMD):企業の財務・戦略的SWOT分析
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • Aurora Diagnostics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aurora Diagnostics LLC (Aurora Diagnostics) is a healthcare service provider that offers hospital and pathology services. The center’s pathology services include gastrointestinal pathology services, heamato-pathology services, dermatology services, urologic pathology, pathology consultation, …
  • Purdue Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Purdue Pharma Inc (Purdue Pharma Canada), a subsidiary of Purdue Pharma LP is a research-based pharmaceutical company that offers services such as development, manufacturing and commercialization of medicines for patients and healthcare professionals. The company portfolio of products includ …
  • GE Healthcare:企業の戦略・SWOT・財務分析
    GE Healthcare - Strategy, SWOT and Corporate Finance Report Summary GE Healthcare - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Vancive Medical Technologies:医療機器:M&Aディール及び事業提携情報
    Summary Vancive Medical Technologies (Vancive) is a medical technology company with expertise in adhesive chemistries and medical technologies focused on pressure-sensitive adhesives for medical applications. The company provides product portfolio such as medical adhesive tapes, negative pressure wo …
  • Nippon Soda Co Ltd (4041):企業の財務・戦略的SWOT分析
    Nippon Soda Co Ltd (4041) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Elbit Imaging Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Elbit Imaging Ltd (Elbit), formerly Elbit Medical Imaging Ltd is a diversified company that operates through various business segments including commercial centers, hotel, medical industries and devices, and plots in India. The company’s commercial centers segment includes initiation, constr …
  • Tredegar Corp (TG):企業の財務・戦略的SWOT分析
    Tredegar Corp (TG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Ironwood Pharmaceuticals Inc (IRWD):企業の財務・戦略的SWOT分析
    Ironwood Pharmaceuticals Inc (IRWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sohu.com Ltd. (SOHU):企業の財務・戦略的SWOT分析
    Sohu.com Ltd. (SOHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆